Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Molecular Therapy Oncolytics|October 7, 2020
Arming HSV-Based Oncolytic Viruses with the Ability to Redirect the Host's Innate Antiviral Immunity to Attack Tumor CellsXinping Fu, Lihua Tao, Wanfu Wu, et al.
BMC Cancer|December 18, 2015
Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine modelsArmando Rivera, Xinping Fu, Lihua Tao, et al.
International Journal of Cancer|December 4, 2010
Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replicationXinping Fu, Lihua Tao, Armando Rivera, et al.
International Journal of Cancer|May 11, 2013
Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle deliveryXinping Fu, Armando Rivera, Lihua Tao, et al.
Oncotarget|December 3, 2014
An HSV-2 based oncolytic virus can function as an attractant to guide migration of adoptively transferred T cells to tumor sitesXinping Fu, Armando Rivera, Lihua Tao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2012
Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activityXinping Fu, Armando Rivera, Lihua Tao, et al.
The Prostate|May 7, 2004
Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancerMikihito Nakamori, Xinping Fu, Curtis A Pettaway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastomaHongtao Li, Aurelie Dutuor, Lihua Tao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2006
A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virusXinping Fu, Lihua Tao, Rong Cai, et al.
International Journal of Oncology|May 10, 2007
Antitumor effects of two newly constructed oncolytic herpes simplex viruses against renal cell carcinomaXinping Fu, Mikihito Nakamori, Lihua Tao, et al.
Pageof 5